Sign Up Now to Download a Free Research Report on AMRN
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? Amarin Corporation Plc
Amarin shares declined 5.75 percent on volume of 11.66 million shares traded to close at $6.39. On Tuesday, rival drug maker, AstraZeneca plc, purchased Omthera Pharmaceuticals Inc. for approximately $260 million. Omthera is currently developing a fish oil-based treatment that could potentially compete with Amarin’s Vascepa.
Going forward ... (see research report)
Subscribe to News Feeds